Schedule of warrant activity (Details) - USD ($) |
12 Months Ended | ||||
---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Feb. 27, 2020 |
|||
Net Investment Income [Line Items] | |||||
Balance at ending | 3,779,243 | 445,252 | |||
Balance at ending | $ 5.89 | $ 15.39 | |||
Granted | 3,787,991 | ||||
Granted | $ 4.97 | ||||
Cancelled/Forfeited | (454,000) | ||||
Cancelled/Forfeited | $ 7.50 | ||||
Balance at ending | 3,779,243 | 3,779,243 | |||
Balance at ending | $ 5.89 | $ 5.89 | |||
Balance at ending | 3 years | ||||
Exercisable at ending | 3,779,243 | ||||
Exercisable at ending | $ 5.89 | ||||
Exercisable at ending | 3 years | ||||
Exercisable at ending | [1] | ||||
Exercise price (in dollars per share) | $ 7,500 | ||||
Warrant [Member] | |||||
Net Investment Income [Line Items] | |||||
Exercise price (in dollars per share) | $ 3.175 | ||||
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The element represents custom share based compensation arrangement by share based payment award equity instruments other than options exercisable weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition The element represents custom share based compensation arrangement by share based payment award equity instruments other than options forfeited in period weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition The element represents custom share based compensation arrangement by share based payment award equity instruments other than options grants in period weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition The element represents custom share based compensation arrangement by share based payment award equity instruments other than options outstanding exercisable weighted average remaining contractual terms. No definition available.
|
X | ||||||||||
- Definition The element represents custom share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average exercise price. No definition available.
|
X | ||||||||||
- Definition The element represents custom share based compensation arrangement by share based payment award non option equity instruments exercisable number. No definition available.
|
X | ||||||||||
- Definition The element represents custom sharebased compensation arrangement by sharebased payment award other than options exercisable intrinsic value1. No definition available.
|
X | ||||||||||
- Details
|